title: The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?
authors.affiliation: Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
authors.forename: Jessica T
authors.initials: JT
authors.lastname: Leonard
authors.affiliation: Department of Medicine, University of Chicago Medical Center, Chicago, Illinois. Electronic address: wstock@medicine.bsd.uchicago.edu.
authors.forename: Wendy
authors.initials: W
authors.lastname: Stock
mesh_terms: D000069439:Dasatinib; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D018365:Neoplasm, Residual; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma
chemical_list: D000069439:Dasatinib